Eledon Pharmaceuticals, Inc. Shares Authorized
Eledon Pharmaceuticals, Inc. (ELDN) had Shares Authorized of 450.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-08-13
- 2026-06-30: Common Stock, Shares Authorized 450.00M shares.
- 2026-06-18: Common Stock, Shares Authorized 450.00M shares.
- 2026-06-17: Common Stock, Shares Authorized 300.00M shares.
- 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2026-06-30 | 450.00M shares 10-Q · filed 2026-08-13 | |
| 2026-06-18 | 450.00M shares 10-Q · filed 2026-08-13 | |
| 2026-06-17 | 300.00M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 300.00M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 300.00M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 300.00M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 300.00M shares 10-Q · filed 2025-08-14 | |
| 2025-06-10 | 300.00M shares 10-Q · filed 2026-08-13 | |
| 2025-06-09 | 200.00M shares 10-Q · filed 2026-08-13 | |
| 2025-03-31 | 200.00M shares 10-Q/A · filed 2025-08-14 | |
| 2024-12-31 | 200.00M shares 10-K · filed 2026-03-19 | |
| 2024-09-30 | 200.00M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 200.00M shares 10-Q · filed 2024-08-19 | |
| 2024-03-31 | 200.00M shares 10-Q/A · filed 2024-08-19 | |
| 2023-12-31 | 200.00M shares 10-K/A · filed 2025-08-14 | |
| 2023-09-30 | 200.00M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 200.00M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 200.00M shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 200.00M shares 10-K/A · filed 2024-08-19 | |
| 2022-09-30 | 200.00M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 200.00M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 200.00M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 200.00M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 200.00M shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 200.00M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 200.00M shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 200.00M shares 10-K · filed 2022-03-24 | |
| 2020-09-30 | 200.00M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 200.00M shares 10-Q · filed 2020-08-14 | |
| 2020-03-31 | 200.00M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 200.00M shares 10-K · filed 2021-03-31 | |
| 2019-09-30 | 200.00M shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 200.00M shares 10-Q · filed 2019-08-13 | |
| 2019-03-31 | 200.00M shares 10-Q · filed 2019-05-14 | |
| 2018-12-31 | 200.00M shares 10-K · filed 2020-03-17 | |
| 2018-09-30 | 200.00M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 200.00M shares 10-Q · filed 2018-08-07 | |
| 2018-03-31 | 200.00M shares 10-Q · filed 2018-05-11 | |
| 2017-12-31 | 200.00M shares 10-K · filed 2019-03-28 | |
| 2017-09-30 | 200.00M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 200.00M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 200.00M shares 10-Q · filed 2017-05-03 | |
| 2016-12-31 | 31.48M shares 10-K · filed 2018-04-02 | 200.00M shares 10-K · filed 2017-03-03 |
| 2016-09-30 | 200.00M shares 10-Q · filed 2016-11-03 | |
| 2016-06-30 | 200.00M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 200.00M shares 10-Q · filed 2016-05-10 | |
| 2015-12-31 | 200.00M shares 10-K · filed 2017-03-03 | |
| 2015-09-30 | 200.00M shares 10-Q · filed 2015-11-10 | |
| 2015-06-30 | 200.00M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 173.02M shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 200.00M shares 10-K · filed 2016-03-10 | |
| 2014-09-30 | 200.00M shares 10-Q · filed 2014-11-13 | |
| 2013-12-31 | 173.02M shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |